Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C017199 |
2',3'-dialdehyde ATP |
2',3'-dialdehyde ATP binds to and results in decreased activity of P2RX7 protein | affects binding|decreases activity | 15258577
|
C010914 |
2,4-diaminotoluene |
2,4-diaminotoluene results in decreased expression of P2RX7 mRNA | decreases expression | 20713471
|
D000255 |
Adenosine Triphosphate |
P2RX7 protein affects the reaction [Adenosine Triphosphate results in increased secretion of SELL protein] | affects reaction|increases secretion | 11003599
|
D000255 |
Adenosine Triphosphate |
P2RX7 protein affects the reaction [Adenosine Triphosphate results in increased transport of Barium] | affects reaction|increases transport | 11003599
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of P2RX7 mRNA | affects expression | 16483693
|
D001464 |
Barium |
P2RX7 protein affects the reaction [Adenosine Triphosphate results in increased transport of Barium] | affects reaction|increases transport | 11003599
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of P2RX7 mRNA | decreases expression | 20064835
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of P2RX7 mRNA | decreases expression | 20713471
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of P2RX7 mRNA | affects expression | 17484886
|
C004692 |
coomassie Brilliant Blue |
coomassie Brilliant Blue binds to and results in decreased activity of P2RX7 protein | affects binding|decreases activity | 19666625
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of P2RX7 mRNA | increases expression | 20106945
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of P2RX7 mRNA | increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of P2RX7 mRNA] | decreases reaction|increases expression | 17942915
|
D004317 |
Doxorubicin |
Doxorubicin affects the expression of P2RX7 | affects expression | 17402594
|
D004996 |
Ethidium |
P2RX7 gene polymorphism results in decreased transport of Ethidium | decreases transport | 16263709
|
D004996 |
Ethidium |
P2RX7 protein results in increased transport of Ethidium | increases transport | 16263709
|
D007501 |
Iron |
Iron deficiency results in increased expression of P2RX7 mRNA | increases expression | 20368581
|
D007657 |
Ketone Bodies |
Ketone Bodies results in decreased expression of P2RX7 mRNA | decreases expression | 16807920
|
D008748 |
Methylcholanthrene |
Methylcholanthrene results in decreased expression of P2RX7 mRNA | decreases expression | 20713471
|
D018817 |
N-Methyl-3,4-methylenedioxyamphetamine |
N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of P2RX7 mRNA | decreases expression | 19285098
|
C077792 |
pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid |
pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid binds to and results in decreased activity of P2RX7 protein | affects binding|decreases activity | 15258577
|
C009250 |
sevoflurane |
sevoflurane affects the expression of P2RX7 mRNA | affects expression | 15967596
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.52 | 18287403 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.42 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
4.42 | 17418594 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
11.08 | 6695378 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
11.08 | 10737359 6695378 |
MESH:D000236 |
Adenoma |
|
Methylcholanthrene |
11.08 | 10545420 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
3.86 | 16434500 17162532 19061943 18056438 19052882 17620307 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.50 | 21441931 |
MESH:D019896 |
alpha 1-Antitrypsin Deficiency |
|
Iron |
5.62 | 16640825 |
MESH:D000544 |
Alzheimer Disease |
|
Iron |
2.99 | 16563566 16640825 |
MESH:D000740 |
Anemia |
|
Iron |
4.33 | 16434484 16566752 |
MESH:D018798 |
Anemia, Iron-Deficiency |
|
Iron |
4.61 | 17147795 17375513 16569441 17162259 17163184 |
MESH:D000756 |
Anemia, Sideroblastic |
|
Iron |
4.77 | 16910769 |
MESH:D000855 |
Anorexia |
|
N-Methyl-3,4-methylenedioxyamphetamine |
5.28 | 15146954 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.03 | 19183758 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Iron |
4.33 | 16604332 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Iron |
5.41 | 15336622 |
MESH:D050197 |
Atherosclerosis |
|
Iron |
7.04 | 16640825 16632123 |
MESH:D050197 |
Atherosclerosis |
|
Methylcholanthrene |
7.04 | 11922910 |
MESH:D001321 |
Autistic Disorder |
|
Iron |
2.79 | 17352947 |
MESH:D001424 |
Bacterial Infections |
|
Iron |
5.16 | 16640825 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.67 | 14601052 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.77 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
2,4-diaminotoluene |
2.35 | 11921183 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.35 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.35 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.35 | 15136595 17983394 18695136 15692762 16264153 18382427 19526202 18628466 15939500 15994142 16595493 16115903 15634643 16826403 16935488 11325840 16322301 18234424 15668708 17426702 16096432 17369602 15993339 15567936 |
MESH:D001943 |
Breast Neoplasms |
|
Methylcholanthrene |
2.35 | 17474063 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.74 | 16097048 15673190 18705752 15721981 16124888 16227642 16192424 15700767 10355542 3786805 16011737 16050911 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.78 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Methylcholanthrene |
3.93 | 10545420 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
4.60 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
4.60 | 19383236 16288022 20007298 17173139 20524982 16878318 11831363 16807293 19107877 17761372 18691550 3581430 17428255 19919837 10672840 3084413 18494052 19394651 21159647 18788625 19418558 19701751 18665156 19052882 19822196 18506893 20432363 19519916 17055752 16502159 16698587 17978847 18971187 19539802 20935162 16328049 16569478 20514400 20101231 18785209 16540662 17138121 10737359 18393292 18978308 20727157 16681979 19335982 16830150 19171122 20512989 20084675 20214788 18210153 16779866 18056438 17162532 16935385 19208518 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
4.60 | 16023760 16234567 18059187 17876044 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.14 | 16201981 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.65 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
4.65 | 6189445 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
8.07 | 18627295 15792986 17924179 16242529 17329180 15811867 16278810 17007740 15505089 17519947 17351982 17308081 17928571 16455267 16952015 17974986 16109756 15476868 16651473 16612575 16364871 17382496 16731534 17131338 16269455 |
MESH:D009202 |
Cardiomyopathies |
|
Iron |
8.07 | 16640825 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
6.14 | 17334414 16243910 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Iron |
6.14 | 16604332 |
MESH:D002386 |
Cataract |
|
Adenosine Triphosphate |
4.58 | 15003327 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
11.08 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
11.08 | 17174075 2727394 7505956 21159647 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylcholanthrene |
11.08 | 16192471 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
3.65 | 19052882 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
2.88 | 19486331 |
MESH:D003110 |
Colonic Neoplasms |
|
Iron |
2.88 | 16640825 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.14 | 18802399 18259882 |
MESH:D003920 |
Diabetes Mellitus |
|
Iron |
4.41 | 16604332 16640825 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Iron |
3.34 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
4.71 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Iron |
4.71 | 16506275 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
6.24 | 7179309 15968718 15027814 19085960 10092053 9327722 6884620 15998439 19336974 17522070 3786805 10915739 2869522 6623471 7120509 4309450 3732212 7440962 11566570 16227642 16177239 21278145 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
6.24 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
6.24 | 17416283 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
3.64 | 18602426 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.42 | 17359293 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.13 | 18037988 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.09 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.00 | 16530937 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
18.49 | 17595544 15959796 61145 12795759 16239168 12631006 19224547 16045604 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
18.49 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
18.49 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
Iron |
18.49 | 16640825 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.55 | 19069698 |
MESH:D005354 |
Fibrosarcoma |
|
Methylcholanthrene |
4.90 | 10962813 14633661 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
8.54 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.54 | 12639820 12168785 |
MESH:D005621 |
Friedreich Ataxia |
|
Iron |
5.39 | 16640825 16604332 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.18 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.32 | 17150277 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.50 | 15692506 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
2.63 | 20471113 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.45 | 16879835 16244371 14766674 16707910 16244372 18674790 18006777 16144979 16495754 12587719 17875725 17888722 16330681 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.31 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.86 | 15692506 |
MESH:D006432 |
Hemochromatosis |
|
Iron |
4.46 | 16640825 17053826 16604332 17255318 16574947 17236123 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.39 | 15720958 |
MESH:D006486 |
Hemosiderosis |
|
Iron |
5.19 | 16604332 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.55 | 19110552 19900420 |
MESH:D006525 |
Hepatitis, Viral, Human |
|
Iron |
5.44 | 16640825 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Iron |
4.90 | 17182432 |
MESH:D006529 |
Hepatomegaly |
|
Iron |
4.28 | 16890145 |
MESH:D015658 |
HIV Infections |
|
Iron |
3.65 | 16597321 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.37 | 15147373 17606976 18501091 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.50 | 16899240 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.08 | 10903974 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
4.05 | 15338365 |
MESH:D007006 |
Hypogonadism |
|
Iron |
4.37 | 16640825 |
MESH:D007037 |
Hypothyroidism |
|
Iron |
5.04 | 16640825 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
2.36 | 18785209 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Iron |
4.99 | 17163184 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.41 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.02 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
6.02 | 15369732 16775033 15699352 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.11 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.70 | 12371664 |
MESH:D007859 |
Learning Disorders |
|
sevoflurane |
4.73 | 19212262 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.13 | 16085563 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
marker/mechanism |
|
| 11003599 |
MESH:D020961 |
Lewy Body Disease |
|
Iron |
5.39 | 16563566 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
10.99 | 16239168 16221502 21278145 17174718 11408273 17334410 16943688 11903743 17157831 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
10.99 | 18665156 18407596 20032147 18522880 19638242 |
MESH:D008103 |
Liver Cirrhosis |
|
Iron |
10.99 | 16640825 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
2.60 | 17698563 16192424 17823541 17976157 18277467 15650968 18317297 15123356 18210741 17631135 15931870 16027843 14724832 18420326 16015684 15362042 17922224 17708605 18054572 12632514 18481824 12586293 18376398 15730626 16248980 17525996 16638106 15893842 15925388 13678700 16116963 17900296 17944888 18187930 12445418 17761835 14512876 17640975 12898905 16011737 12389079 18263696 15338365 12445421 18412020 17721639 18251166 10355542 18705752 18429990 18006644 18339082 17557913 15959796 17805973 12667390 15057751 18279442 16136751 12609069 14716496 17766677 14620537 18418968 12666154 15052691 17714472 16033810 14748882 12958196 17565644 11481614 15370692 15996030 12546737 20821823 17481882 12741479 17869086 18156304 18472332 14716833 18166357 12632512 15818738 15673190 18395914 18395095 12649538 16097048 18472094 18205269 15876570 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
2.60 | 16439617 16595196 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
4.03 | 15720792 15830285 17285989 16964402 16246199 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
4.03 | 17034775 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Iron |
4.97 | 17207112 16737972 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.12 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.65 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
10.62 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
10.62 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
10.62 | 20101389 20137499 15175105 12771043 2422723 19638242 19090486 21047994 16942905 20452335 2862719 20405173 18648771 19499222 20434301 19426721 15885732 21278145 19427195 19294768 19256749 10737359 20118626 19812893 19642983 20492335 20501860 18754104 20583210 12112319 19255062 18644402 21071580 19690152 19996281 21167192 18978307 19850985 18977376 19551842 9163691 19833225 19254457 19073162 |
MESH:D008113 |
Liver Neoplasms |
|
Iron |
10.62 | 16640825 20302851 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
13.96 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
13.96 | 18253720 16267830 18164116 18093689 21159647 19009564 2563599 18079962 19126423 18544905 18308698 3124819 16842330 17942915 17174075 18775883 19004024 19539802 19519916 18282651 17854601 9362446 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
13.96 | 17085340 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Methylcholanthrene |
13.96 | 598648 1399818 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
6.56 | 17053015 6695378 18520028 20064080 18569708 20135361 18816296 20869020 20464547 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
6.56 | 20512841 21163286 6695378 20970405 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
6.56 | 6189445 17418594 |
MESH:D008175 |
Lung Neoplasms |
|
Iron |
6.56 | 16640825 |
MESH:D008175 |
Lung Neoplasms |
|
Methylcholanthrene |
6.56 | 11893704 15390079 6695378 16271038 10545420 1399818 20970405 21163286 20512841 9230183 7750092 17909032 16337739 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.43 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.75 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.53 | 15621674 |
MESH:D008268 |
Macular Degeneration |
|
Iron |
3.96 | 16640825 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
2,4-diaminotoluene |
6.40 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
6.40 | 15458769 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
2.28 | 16827129 |
MESH:D008569 |
Memory Disorders |
|
sevoflurane |
4.71 | 19212262 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.04 | 17638057 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.76 | 16801185 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.46 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.15 | 16381670 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.75 | 17415656 |
MESH:D020528 |
Multiple Sclerosis, Chronic Progressive |
|
Iron |
5.64 | 17086897 |
MESH:D009181 |
Mycoses |
|
Iron |
5.44 | 16640825 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
2.93 | 19429709 15857846 |
MESH:D017202 |
Myocardial Ischemia |
|
Iron |
4.41 | 16604332 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Iron |
4.23 | 16604332 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
5.82 | 3581430 9029167 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
5.82 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
2.15 | 11141357 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.73 | 16636307 16899518 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.41 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
15.59 | 18481113 19348381 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
15.59 | 16889571 15640375 |
MESH:D009404 |
Nephrotic Syndrome |
|
Iron |
15.59 | 17178036 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.24 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
8.56 | 20387270 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Iron |
8.56 | 17296847 16604332 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.09 | 20387270 |
MESH:D010003 |
Osteoarthritis |
|
Iron |
3.94 | 16640825 |
MESH:D010024 |
Osteoporosis |
|
Iron |
3.83 | 16640825 16648989 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.08 | 15930896 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
2.41 | 16540662 |
MESH:D010212 |
Papilloma |
|
Iron |
4.44 | 12065085 |
MESH:D020447 |
Parasomnias |
|
Iron |
5.99 | 17352947 |
MESH:D010300 |
Parkinson Disease |
|
Iron |
3.30 | 16563566 16640825 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.13 | 17983394 |
MESH:D010900 |
Pituitary Diseases |
|
Iron |
5.64 | 16604332 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.13 | 17638057 |
MESH:D011041 |
Poisoning |
|
Iron |
4.25 | 16604332 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Iron |
4.94 | 16640825 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
8.82 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
8.82 | 2563599 |
MESH:D011225 |
Pre-Eclampsia |
|
Iron |
4.39 | 16640825 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.30 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
3.30 | 15897917 18437689 16868541 15749863 16888761 16729912 |
MESH:D011528 |
Protozoan Infections |
|
Iron |
5.99 | 16640825 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.21 | 16882103 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.18 | 17922066 |
MESH:D012148 |
Restless Legs Syndrome |
|
Iron |
4.51 | 16930377 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.95 | 17710206 17203757 15675481 15625365 18313854 16767912 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.20 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.75 | 17846226 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
9.51 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
9.51 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Iron |
9.51 | 12065085 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.53 | 17203757 15625365 16767912 |
MESH:D013119 |
Spinal Cord Injuries |
therapeutic |
|
| 15258577 |
MESH:D013119 |
Spinal Cord Injuries |
|
2',3'-dialdehyde ATP |
19.43 | 15258577 |
MESH:D013119 |
Spinal Cord Injuries |
|
coomassie Brilliant Blue |
19.43 | 19666625 |
MESH:D013119 |
Spinal Cord Injuries |
|
pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid |
19.43 | 15258577 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.32 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
2.32 | 18456281 |
MESH:D013398 |
Sudden Infant Death |
|
Iron |
5.41 | 16640825 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
7.18 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
7.18 | 17909728 16010429 |
MESH:D014376 |
Tuberculosis |
|
Iron |
4.06 | 16597321 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
5.09 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
5.09 | 17653716 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.96 | 1336536 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.18 | 17638931 16364871 17678736 17334414 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.41 | 17120751 |